Myxedema Coma Following the Administration of Gonadotropin-releasing Hormone Agonist Complicated by Acute Pancreatitis-Reference-Cited by-同舟云学术

Myxedema Coma Following the Administration of Gonadotropin-releasing Hormone Agonist Complicated by Acute Pancreatitis

Published:2018-11-01 Issue:21 Volume:57 Page:3117-3122
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Gocho Naoki¹,Aoki Ema¹,Okada Chiho¹,Hirashima Takeshi¹

Affiliation:

1. Diabetes Center, Ebina General Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/21/57_0639-17/_pdf

Reference18 articles.

1. 1. Wilson AC, Meethal SV, Bowen RL, Atwood CS. Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs 16: 1851-1863, 2007.

2. 2. Aoki C, Kasai K. The diagnosis and treatment of myxedema coma. Nihon Rinsho (Jpn J Clin Med) 70: 1995-1999, 2012 (in Japanese, Abstract in English).

3. 3. Eyal O, Rose SR. Autoimmune thyroiditis during leuprolide acetate treatment. J Pediatr 144: 394-396, 2004.

4. 4. Kasayama S, Miyake S, Samejima Y. Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate. Endocr J 47: 783-785, 2000.

5. 5. Han EJ, Song HD, Yang JH, et al. Thyroid dysfunction associated with administration of the long acting gonadotropin releasing hormone agonist. Endocrinol Metab (Seoul) 28: 221-225, 2013.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist;European Journal of Medicinal Chemistry;2022-11

2. Discovery of the Thieno[2,3-d]Pyrimidine-2,4-Dione Derivative 21a: A Potent and Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist;SSRN Electronic Journal;2022

3. Antihistamines/leuprorelin;Reactions Weekly;2018-12